&w=3840&q=100)
Pune scientists isolating Covid sub-variants behind India's new cases
Amid the recent rise of new Covid cases in India, the National Institute of Virology (NIV) on Wednesday said it is conducting genome sequencing and isolating four new sub-variants of the Omicron virus that are believed to be responsible for the new outbreak.
Genome sequencing is the process of determining the complete DNA sequence of an organism, giving scientists information about the reproduction, evolution and functions of the organism.
This effort will help in assessing vaccine effectiveness and whether a new vaccine needs to be developed, said Dr Naveen Kumar, director of the Pune-based NIV, which operates under the aegis of the Indian Council of Medical Research (ICMR).
An upsurge of Covid cases has been reported since the second week of April this year, beginning in southeast Asia.
"Scientists at NIV are doing monitoring, genome sequencing and isolating the new variants. The strain which was circulating in Singapore was also found in India five to six weeks ago," Dr Kumar said. "Isolation is important to replace the existing vaccine strain if at all it is required. Whether or not this needs to be replaced is something which is to be critically analysed based on the severity of the disease. So far, it appears that the strains are not much severe. However, the decision of making a new vaccine using the currently circulating strains is taken by policymakers after extensive discussion."
Kumar said that after genome sequencing of samples across India, four sub-variants of Omicron - LF.7, XFG, JN.1.16 and NB.1.8.1 - have been found. Genomic analysis revealed that the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and since May, it was replaced by the XFG (LF.7 and LP.81.2) recombinant variant.
Whole genome sequences have been submitted to the Indian Biological Data Centre and the Global Initiative on Sharing All Influenza Data, Kumar said.
Currently, two monovalent Omicron-based vaccines are available: Biological E's Corbivax and Serum Institute of India's COVOVAX.
The Covid caseload in the country saw a marginal dip on Wednesday, with 6,483 active cases compared to 6,837 cases on Tuesday.
Since 1 January, 113 deaths due to Covid-19 have been reported, primarily among individuals with pre-existing conditions.
Kerala has seen the steepest dip in caseload; however, it remains the most-affected state, followed by Gujarat, Karnataka and Delhi, according to data released by the Ministry of Health.
Medical experts believe that the current upsurge in cases is a 'mini wave', as the virus is behaving more like a seasonal flu now. They also believe that such seasonal flus will become more common in the near future.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
Labs, private hospitals told to conduct Covid-19 testing per govt. protocols if prescribed by doctors
On the back of a slight surge in Covid-19 RTPCR-positive cases reported across the city, the Pune Municipal Corporation (PMC) on Wednesday issued orders to all private hospitals and laboratories to strictly adhere to the central government's guidelines on Covid-19 testing. The PMC health department issued a letter raising concerns over an alleged rise in unnecessary Covid screening carried out by private doctors and labs in the city. According to civic officials, this unjustified testing is leading to panic among the public besides adding to treatment costs. 'RTPCR tests are being conducted without doctors' prescriptions, which violates testing protocols issued by the state health department. As per current government guidelines, RTPCR testing is mandatory only for all SARI (Severe Acute Respiratory Infection) and 5% ILI (Influenza-like Illness) cases. Healthcare providers advise testing only after a proper medical assessment and in accordance with the protocols,' read the letter issued by the PMC, a copy of which has been seen by Hindustan Times. Dr Nina Borade, PMC health chief said, 'We have attached the official government advisory with the letter and asked all private hospitals and laboratories to strictly implement instructions to ensure targeted and appropriate Covid-19 testing, avoid unnecessary panic, and make efficient use of healthcare resources.' Dr Borade informed that a meeting was held with private laboratories on Tuesday during which the latter were told to strictly follow government guidelines during testing. 'The labs have been asked to carry out testing only as per government protocols and if prescribed by doctors,' she said. Civic officials said that during the review meeting, it was found that Covid RTPCR tests are being carried out in many cases even when it is not necessary as per government protocols like those with mild symptoms such as cold, cough and fever; those returning from travel; employees resuming duty after extended leave; preoperative patients; and those requesting testing without valid medical advice. Meanwhile, genome sequencing reports from B J Medical College have confirmed the presence of the XFG variant in the city. Health officials clarified that this new variant appears to be mild in nature however they emphasised the need to closely monitor patients with comorbidities and those showing SARI symptoms.
News18
4 hours ago
- News18
New Covid Variant ‘Nimbus' Spreads In US, Causes Painful ‘Razor Blade Throat'. What Is It?
Last Updated: Known scientifically as NB.1.8.1, the variant is currently being monitored by the World Health Organization (WHO) and was first detected in China earlier this year. A newly emerging Covid-19 subvariant 'Nimbus' is gaining ground in the United States, causing a distinctive and extremely painful sore throat, commonly described by patients as 'razor blade throat." Known scientifically as NB.1.8.1, the variant is currently being monitored by the World Health Organization (WHO) and was first detected in China earlier this year. According to data from the Centers for Disease Control and Prevention (CDC), Nimbus accounted for approximately 37% of US cases in the two-week period ending June 7. The variant could soon represent up to one-third of global Covid cases, health officials have warned. Nicknamed 'razor throat," the symptom of the Nimbus variant is an intensely painful sore throat, with some patients likening it to 'swallowing shards of glass." This symptom is notably more severe and more common than in previous variants as Dr. Marc Siegel, Fox News' senior medical analyst, said, 'Many of the Covid subvariants have characteristic features. Nimbus is being associated with an unusually sharp sore throat." Other symptoms reported include: nasal congestion or runny nose, fatigue, mild cough, fever, muscle or body aches and nausea or diarrhea. Despite the striking throat pain, Dr. Marc Siegel said that Nimbus does not appear more virulent than earlier strains. Dr. Kenneth Perry, an emergency room physician in South Carolina, noted that the predominant symptoms of Covid continue to shift with each new variant, saying, 'With the new variant, it appears that the sore throat is yet again a prominent symptom. The pain is caused by direct infection and inflammation of the throat's cells." What US Health Agency Has Said On Nimbus? Though the variant is clearly spreading, the CDC noted that NB.1.8.1 is still emerging in terms of genetic sequencing data. A CDC spokesperson told Newsweek that fewer than 20 confirmed genetic sequences of the variant had been documented in US baseline surveillance so far while public health officials remain alert to its rise, particularly in high-population states like California and New York. Dr. Tyler B. Evans, infectious disease expert and CEO of the Wellness and Equity Alliance, said that while Nimbus may not drastically differ from other recent strains, it should still be taken seriously. 'We're still seeing the familiar signs—sore throat, nasal congestion, fatigue, cough," he told Newsweek, adding, 'But in some people, especially the unvaccinated, this can escalate into more severe respiratory symptoms." First Published: June 18, 2025, 18:07 IST
Time of India
4 hours ago
- Time of India
SER to use AI-based system to prevent elephant-train collisions
Rourkela: The South Eastern Railway's Chakradharpur division will implement an Artificial Intelligence-based elephant intrusion detection system (EIDS) to prevent train accidents involving the animals on railway tracks. Tired of too many ads? go ad free now The system, successfully tested on June 15 and 16 along the Barabamboo-Chakradharpur-Lotapahar section, will be installed in elephant corridors like Jareikela, Bhalulata, Barsuan and Bimlagarh areas. "The testing was conducted by different firms and was successful. The system, offering the best coverage for elephant protection, will be selected for installation from among the prospective bidders. This may happen within the next few months," A K Choudhury, senior divisional commercial manager of Chakradharpur, said. EIDS employs a combination of pressure wave sensors, optical fibre cables and AI algorithms to detect approaching elephants. When elephants are detected near the tracks, the system automatically alerts railway officials, allowing them to direct approaching trains to either slow down or stop, preventing potential collisions. For the trial run, two elephants from Vantara, the wildlife rescue in Gujarat, were brought to Chakradharpur. The testing was conducted under the supervision of railway officials from the Chakradharpur division.
